Clinical Trial Update: A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 study of Islatravir and Ulonivirine for people with HIV-1 who have not been treated before is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Islatravir (Islatravir)
• Ulonivirine (MK-8507)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Human Immunodeficiency Virus Type 1 (HIV-1) Infection | Phase 2, Phase 3 | Status: RECRUITING